ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF/BETA pathway and is regulated by miR-26a-5p

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies and the therapeutic outcomes remain undesirable. Increasing evidence shows that aryl hydrocarbon receptor nuclear translocator like 2 (ARNTL2) plays crucial roles in tumorigenesis of multiple tumors. However, the expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhifang, Liu, Tingting, Xue, Wenhua, Fang, Yuanyuan, Chen, Xiaolong, Xu, Lijun, Zhang, Lixia, Guan, Kelei, Pan, Juntao, Zheng, Lili, Qin, Guijun, Wang, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443143/
https://www.ncbi.nlm.nih.gov/pubmed/32826856
http://dx.doi.org/10.1038/s41419-020-02839-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443143/
https://www.ncbi.nlm.nih.gov/pubmed/32826856
http://dx.doi.org/10.1038/s41419-020-02839-6

Ejemplares similares